Shepherd Financial Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $979K | Buy |
6,184
+211
| +4% | +$28.5K | 0.08% | 117 |
|
|
2026
Q1 | $763K | Buy |
5,973
+31
| +0.5% | +$3.87K | 0.07% | 130 |
|
|
2025
Q4 | $724K | Sell |
5,942
-654
| -10% | -$75K | 0.07% | 135 |
|
|
2025
Q3 | $661K | Sell |
6,596
-325
| -5% | -$29.3K | 0.06% | 137 |
|
|
2025
Q2 | $574K | Sell |
6,921
-1,284
| -16% | -$102K | 0.06% | 142 |
|
|
2025
Q1 | $665K | Sell |
8,205
-1,011
| -11% | -$90.4K | 0.08% | 136 |
|
|
2024
Q4 | $830K | Sell |
9,216
-1,234
| -12% | -$120K | 0.1% | 109 |
|
|
2024
Q3 | $1.03M | Buy |
10,450
+1,298
| +14% | +$128K | 0.12% | 95 |
|
|
2024
Q2 | $848K | Buy |
9,152
+296
| +3% | +$26.5K | 0.11% | 108 |
|
|
2024
Q1 | $840K | Buy |
8,856
+1,595
| +22% | +$148K | 0.11% | 113 |
|
|
2023
Q4 | $648K | Sell |
7,261
-10,260
| -59% | -$762K | 0.09% | 125 |
|
|
2023
Q3 | $1.28M | Sell |
17,521
-1,900
| -10% | -$152K | 0.2% | 75 |
|
|
2023
Q2 | $1.62M | Sell |
19,421
-2,126
| -10% | -$178K | 0.25% | 67 |
|
|
2023
Q1 | $1.64M | Buy |
21,547
+1,966
| +10% | +$163K | 0.27% | 61 |
|
|
2022
Q4 | $1.63M | Sell |
19,581
-51
| -0.3% | -$4.13K | 0.29% | 61 |
|
|
2022
Q3 | $1.56M | Buy |
19,632
+11,836
| +152% | +$998K | 0.3% | 61 |
|
|
2022
Q2 | $579K | Sell |
7,796
-233
| -3% | -$17.5K | 0.11% | 102 |
|
|
2022
Q1 | $717K | Sell |
8,029
-5,957
| -43% | -$550K | 0.13% | 103 |
|
|
2021
Q4 | $1.57M | Sell |
13,986
-298
| -2% | -$35.9K | 0.27% | 69 |
|
|
2021
Q3 | $1.8M | Buy |
14,284
+121
| +0.9% | +$15.6K | 0.35% | 59 |
|
|
2021
Q2 | $1.92M | Buy |
14,163
+1,720
| +14% | +$226K | 0.36% | 57 |
|
|
2021
Q1 | $1.69M | Buy |
12,443
+395
| +3% | +$59.1K | 0.37% | 58 |
|
|
2020
Q4 | $1.7M | Buy |
12,048
+340
| +3% | +$43.5K | 0.39% | 61 |
|
|
2020
Q3 | $1.3M | Buy |
11,708
+888
| +8% | +$99.6K | 0.31% | 67 |
|
|
2020
Q2 | $1.21M | Buy |
10,820
+26
| +0.2% | +$2.56K | 0.33% | 56 |
|
|
2020
Q1 | $835K | Sell |
10,794
-650
| -6% | -$57.6K | 0.29% | 56 |
|
|
2019
Q4 | $1.09M | Buy |
11,444
+556
| +5% | +$48.1K | 0.25% | 65 |
|
|
2019
Q3 | $828K | Hold |
10,888
| – | – | 0.21% | 65 |
|
|
2019
Q2 | $955K | Buy |
10,888
+23
| +0.2% | +$1.96K | 0.18% | 63 |
|
|
2019
Q1 | $984K | Buy |
10,865
+353
| +3% | +$30K | 0.19% | 62 |
|
|
2018
Q4 | $753K | Sell |
10,512
-4,713
| -31% | -$380K | 0.16% | 67 |
|
|
2018
Q3 | $1.45M | Hold |
15,225
| – | – | 0.33% | 46 |
|
|
2018
Q2 | $1.47M | Buy |
15,225
+12,253
| +412% | +$1.13M | 0.33% | 46 |
|
|
2018
Q1 | $260K | Buy |
+2,972
| New | +$271K | 0.06% | 101 |
|
Other funds holding XBI
JFG
Shepherd Financial Partners's XBI Position: Q2 2026 in Review
Shepherd Financial Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.5% in Q2 2026, buying an estimated $28.5K and bringing the position to 6,184 shares worth $979K. The position accounts for 0.08% of the portfolio, ranked #117.
Shepherd Financial Partners first reported a position in XBI in Q1 2018 and has held it in 34 quarters since. The position peaked at $1.92M in Q2 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Shepherd Financial Partners held 6,184 shares of State Street SPDR S&P Biotech ETF worth $979K as of Q2 2026.
- Shepherd Financial Partners bought 211 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $28.5K.
- State Street SPDR S&P Biotech ETF made up 0.08% of Shepherd Financial Partners's portfolio in Q2 2026, its #117 holding.
- Shepherd Financial Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 34 quarters since.
- Shepherd Financial Partners's State Street SPDR S&P Biotech ETF position peaked at $1.92M in Q2 2021.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Shepherd Financial Partners's 13F filing for Q2 2026, filed 10 Aug 2026.